- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02696733
Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach
Ultrasound-Guided Obturator Nerve Block for Transurethral Procedures - Interadductor Approach
Study Overview
Status
Intervention / Treatment
Detailed Description
The basic methods for diagnosis and management of bladder cancer are endoscopic procedures. Transurethral resection of bladder tumor (TURBT) is usually performed under spinal anesthesia that does not prevent an unintended stimulation of the obturator nerve (ON) when electroresection is performed on the lateral wall of the bladder. This sensorimotor nerve arises from the lumbar plexus at L2-L4. It innervates the muscles responsible for adducting the thigh and the skin on the surface of the paramedian segment of the thigh. During TURBT, when the bladder has been filled with irrigation fluid, the ON is directly adjacent to the lateral wall of the bladder and it can be stimulated during the electroresection. Sudden contraction of the adductor muscles of the thigh, may lead to perforation of bladder wall with the resectoscope loop.
In the Department of General, Oncologic and Functional Urology, Medical University of Warsaw approximately 500 TURBT are performed every year; 7% of them necessitate the prevention of ON stimulation. Anesthetists perform obturator nerve block (ONB) - the anterior branch, using the stimulator for the identification with the 94% efficacy.
Recently, ultrasound guidance has been used to enhance the safety and efficacy of the nerve blocks that is why we have decided to evaluate the effectiveness of ONB performed with ultrasounds.
An approval from the Medical University of Warsaw Bioethical Committee has been obtained. Patients need to give written informed consent to participate in the study.
It is anticipated that 100 patients with TURBT performed under spinal anesthesia that, after the urologist decision, necessitate the ONB will be enrolled in this study.
Before the procedure an oral premedication is given. After admission to the operating room, intravenous access is established and the patient receives a drip infusion of 500 ml 0.9% Natrium Chloratum with an antibiotic (2nd generation cephalosporin). Constant monitoring is ensured of ECG, heart rate, and pulse oxymetry. Non-invasive blood pressure measurement is taken every five minutes. To maintain patients' blood oxygenation, oxygen is delivered with the use of a facemask. Spinal anesthesia is performed with patients in the sitting position, most frequently in the L3 L4 space (in the case of technical difficulties - L2 L3 or L4 L5) using 8-15 mg 0.5% hyperbaric bupivacaine depending on the patient's anthropometric parameters. The needles used are 25-27G pencil point. After drug administration, the patient is placed in the supine position.
Upon reaching the appropriate anesthesia level (Th10), which blocks conduction in the sensory nerve fibers of the bladder, the patient is placed in the lithotomy position. In the case of tumors located on the lateral wall of the bladder, the safety of TURBT is ensured using a neurotest performed by an urologist with a nerve stimulator built into the resectoscope (Neurotester FB2, ERBE). The extremity movement leads to the decision to block the ON.
Ultrasound-guided ONB procedure:
The patient remains in the lithotomy position. For nerve identification a linear transducer is used. It is placed next to the grain to visualize three adductor muscles. Between adductor longus and adductor brevis, in fascial plane, an anterior branch of obturator should be visualized. The needle is advanced toward the nerve in an out-of-plane trajectory. The local anesthetic is injected after heme-negative aspiration. The resistance during injection is avoided to reduce the risk of intraneural injection. If there are problems with nerve identification the anesthetic is injected in fascial plane between adductors muscles - longus and brevis.
10 ml of 2% lidocaine is used for single block and 2 x 10 ml of 2% lidocaine with epinephrine when bilateral one is needed.
Before TURBT starts again, the urologist once more perform the neurotest to evaluate the ONB efficacy.
After enrolling 50 patients to the study the results will be evaluated and the decision whether to decrease the amount of 10 ml of 2% lidocaine for injection will be taken.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Karolina Dobronska, MD
- Phone Number: +48 22 502 17 27
- Email: karolinapladzyk@gmail.com
Study Contact Backup
- Name: Lidia I Jureczko, PhD MD
- Phone Number: +48 22 502 17 27
- Email: jureczko@gmail.com
Study Locations
-
-
-
Warsaw, Poland, 02-005
- Recruiting
- I Department od Anaesthesiology and Intensive Care
-
Contact:
- Karolina Dobronska, MD
- Phone Number: +48 22 501 17 27
- Email: karolinapladzyk@gmail.com
-
Contact:
- Lidia I Jureczko, PhD MD
- Phone Number: +48 22 501 17 27
- Email: jureczko@gmail.com
-
Principal Investigator:
- Karolina Dobronska, MD
-
Sub-Investigator:
- Lidia I Jureczko, PhD MD
-
Warsaw, Poland, 02-005
- Recruiting
- I Department of Anaesthesiology and Intensive Care, Medical University of Warsaw
-
Contact:
- Karolina Dobronska, MD
- Phone Number: +48 22 501 17 27
- Email: karolinapladzyk@gmail.com
-
Contact:
- Lidia I Jureczko, PhD MD
- Phone Number: +48 22 501 17 27
- Email: jureczko@gmail.com
-
Principal Investigator:
- Karolina Dobronska, MD
-
Sub-Investigator:
- Lidia I Jureczko, PhD MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- informed consent
- bladder tumor located on the lateral wall
- transurethral resection of the bladder tumor
- urologist decision that there is a risk of the stimulation of obturator nerve during resection
- spinal anesthesia
Exclusion Criteria:
- patients' refusal
- contraindications for spinal anesthesia
- skin lesions at injection site
- patients who really did not need ONB.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: UG - ONB
Patients with the bladder tumor located on the lateral wall, with the high risk of adductor muscles contraction during TURBT under spinal anesthesia.
|
Ultrasound-guided obturator nerve localization
Other Names:
local anesthetic used to block the obturator nerve
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effectiveness of ultrasound guided obturator nerve block - evaluated by a number of participants having transurethral resection of bladder tumor without unintended obturator nerve stimulation.
Time Frame: 30 months
|
The investigator evaluates whether the urologist was able to perform safe electroresection of bladder tumor with no extremity movement.
All extremity movements due to obturator nerve stimulation and all necessities to perform general anesthesia will be counted as unsuccessful ultrasound - guided ONB.
|
30 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success rate of obturator nerve visualization with ultrasounds
Time Frame: 30 months
|
The investigators evaluate whether it was possible to visualize the obturator nerve in the fascial plane
|
30 months
|
Efficacy of ONB - measured with nerve stimulator built in the resectoscope
Time Frame: 30 months
|
A nerve stimulator (Neurotester FB2, ERBE) is used to evaluate the efficacy of the nerve block.
Current flow settings are progressively marked relative to a 1-5 scale .
|
30 months
|
Safety of ultrasound-guided ONB measured by number of complications
Time Frame: 30 months
|
hematoma , lidocaine overdose symptoms, bladder perforation,obturator nerve injury
|
30 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Pladzyk K, Jureczko L, Lazowski T. Over 500 obturator nerve blocks in the lithotomy position during transurethral resection of bladder tumor. Cent European J Urol. 2012;65(2):67-70. doi: 10.5173/ceju.2012.02.art2. Epub 2012 Jun 12.
- Thallaj A, Rabah D. Efficacy of ultrasound-guided obturator nerve block in transurethral surgery. Saudi J Anaesth. 2011 Jan;5(1):42-4. doi: 10.4103/1658-354X.76507.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neoplasms
- Urologic Neoplasms
- Urogenital Neoplasms
- Neoplasms by Site
- Urologic Diseases
- Urinary Bladder Diseases
- Urinary Bladder Neoplasms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Anti-Infective Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Anti-Bacterial Agents
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
- Cephalosporins
Other Study ID Numbers
- U/1/2014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Bladder Neoplasms
-
Peking University First HospitalRecruitingUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors | Neoplasms, BladderChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Bristol-Myers SquibbRecruitingUrinary Bladder Cancer | Invasive Bladder CancerNetherlands
-
GlaxoSmithKlineCompletedNeoplasms, Urinary BladderBelgium
-
Memorial Sloan Kettering Cancer CenterPfizerCompletedBladder Cancer | Urinary BladderUnited States
-
Mansoura UniversityCompletedBladder Cancer | Bladder Disease | Bladder Neoplasm | Micro-RNAEgypt
-
Medical University of ViennaUniversity of Turin, ItalyRecruitingT1 Urinary Bladder CancerAustria
-
Zhujiang HospitalRecruiting
-
Chinese University of Hong KongUnknownUrinary Bladder TumorHong Kong
-
Ziv HospitalAzrieli Faculty of medicine, Bar Ilan University, Safed, ILNot yet recruitingBladder Neoplasm
-
Ziv HospitalNot yet recruitingBladder Neoplasm
Clinical Trials on Ultrasound
-
Ahram Canadian UniversityCompletedCarpal Tunnel Syndrome | Median Neuropathy, Carpal TunnelEgypt
-
Eskisehir Osmangazi UniversityCompletedCarpal Tunnel Syndrome
-
Cairo UniversityUnknown
-
Ohio State University Comprehensive Cancer CenterWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Mayo ClinicNational Cancer Institute (NCI); National Institute for Biomedical Imaging...RecruitingBreast CarcinomaUnited States
-
Bursa Yüksek İhtisas Education and Research HospitalNot yet recruitingShoulder Impingement Syndrome | Shoulder Pain
-
John PelleritoGeneral ElectricActive, not recruiting
-
Oregon Health and Science UniversityRecruiting
-
Yale UniversityCompletedPneumonia | Pulmonary Edema | DyspneaUnited States